ICD-10-CM code · FY2027
R11.2 Nausea with vomiting, unspecified
BillableValid for claims as a specific diagnosis code
About R11.2
- Code
- R11.2
- Billable
- Yes
- Short description
- Nausea with vomiting, unspecified
- Category
- R11 Nausea and vomiting
- Block
- R10-R19 Symptoms and signs involving the digestive system and abdomen
- Chapter
- 18 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Code set
- FY2027, October 1, 2026 to September 30, 2027
Ask EvidencePulse about nausea and vomiting
Answers from the published evidence, with every study linked. The question goes into the box; nothing is sent until you press Ask.
Coding notes for R11.2
Applicable to Other names for conditions reported with this code.
- Persistent nausea with vomiting NOS
Also applies, from R11 Nausea and vomiting
Excludes1 Not coded here: never report these together with this code (use the code given instead).
Block R10-R19 notes (apply to every code in it)
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- congenital or infantile pylorospasm (Q40.0)
- gastrointestinal hemorrhage (K92.0-K92.2)
- intestinal obstruction (K56.-)
- newborn gastrointestinal hemorrhage (P54.0-P54.3)
- newborn intestinal obstruction (P76.-)
- pylorospasm (K31.3)
- signs and symptoms involving the urinary system (R30-R39)
- symptoms referable to female genital organs (N94.-)
- symptoms referable to male genital organs (N48-N50)
Chapter 18 notes (apply to every code in it)
Note
- This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
- Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
- The conditions and signs or symptoms included in categories R00-R94 consist of:
- (a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
- (b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
- (c) provisional diagnosis in a patient who failed to return for further investigation or care;
- (d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
- (e) cases in which a more precise diagnosis was not available for any other reason;
- (f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
Related codes in R11
- R11.0 NauseaBillable
- R11.1 VomitingHeader
Latest research on nausea and vomiting
- Fosrolapitant/Palonosetron in Chemotherapy-Induced Nausea and Vomiting
- Aprepitant regimen is linked to decreased chemotherapy-induced nausea and vomiting in women
- In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks
- Dexmedetomidine (Precedex) may offer similar analgesic efficacy as remifentanil (Ultiva) with fewer adverse effects in adults undergoing sleeve gastrectomy
- 2 Minute Medicine Rewind October 5th, 2026
Landmark trials from 2MM Classics
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plans